Insights from 2023 SABCS
Playback speed
10 seconds
SABCS 2023 Insights: "CAMBRIA 1 Study of Extended Adjuvant Therapy With Camizestrant vs. Standard ET in Patients With ER+/HER2- Early BC and an Intermediate/High Risk of Recurrence"
By
Insights from 2023 SABCS
FEATURING
Erika Hamilton
By
Insights from 2023 SABCS
FEATURING
Erika Hamilton
367 views
December 19, 2023
Comments 0
Login to view comments.
Click here to Login
Videos